These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20191455)

  • 41. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of the nephrologist in the management of vascular access for hemodialysis].
    D'Amico M; Fraticelli M; Mangano S; Bonforte G
    G Ital Nefrol; 2007; 24(6):605-8. PubMed ID: 18278765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why do we need outcomes research in end stage renal disease?
    Nicolucci A; Procaccini DA
    J Nephrol; 2000; 13(6):401-4. PubMed ID: 11132755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of clinical outcomes in peritoneal dialysis and hemodialysis].
    Roob JM
    Wien Klin Wochenschr; 2005; 117 Suppl 6():60-8. PubMed ID: 16437335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis.
    Nesrallah GE; Mustafa RA; MacRae J; Pauly RP; Perkins DN; Gangji A; Rioux JP; Steele A; Suri RS; Chan CT; Copland M; Komenda P; McFarlane PA; Pierratos A; Lindsay R; Zimmerman DL
    Am J Kidney Dis; 2013 Jul; 62(1):187-98. PubMed ID: 23566638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement.
    Wauters JP; Lameire N; Davison A; Ritz E
    Nephrol Dial Transplant; 2005 Mar; 20(3):490-6. PubMed ID: 15735240
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of the primary care physician in diagnosis and treatment of early renal damage.
    Cueto-Manzano AM; Cortés-Sanabria L; Martínez-Ramírez HR
    Ethn Dis; 2009; 19(1 Suppl 1):S1-68-72. PubMed ID: 19484880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results of the international hemodialysis study DOPPS in Spain and Europe].
    Cruz JM; Piera L; Bragg-Gresham JL; Feldman H; Port FK
    Nefrologia; 2003; 23(5):437-43. PubMed ID: 14658170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practice guidelines do improve patient outcomes: association or causation?
    Levin A
    Blood Purif; 2008; 26(1):67-72. PubMed ID: 18182800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The best outcomes: are they in for-profit or not-for-profit units?
    Sadler JH
    Nephrol News Issues; 2000 Mar; 14(4):46-8. PubMed ID: 11075102
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment options for end stage renal disease.
    Crawford PW; Lerma EV
    Prim Care; 2008 Sep; 35(3):407-32, v. PubMed ID: 18710662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can we ameliorate quality of life in chronic kidney disease? The nephrologist's point of view.
    Ritz E
    J Nephrol; 2008; 21 Suppl 13():S9-11. PubMed ID: 18446726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The detection of advanced chronic kidney disease by surveillance of elevated plasma creatinines--a five-year experience.
    Innes A
    Nephrol Dial Transplant; 2008 Aug; 23(8):2571-5. PubMed ID: 18390892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into nephrologist training, clinical practice, and dialysis choice.
    Merighi JR; Schatell DR; Bragg-Gresham JL; Witten B; Mehrotra R
    Hemodial Int; 2012 Apr; 16(2):242-51. PubMed ID: 22151183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 'centre effect' in nephrology: what do differences between nephrology centres tell us about clinical performance in patient management?
    Hodsman A; Ben-Shlomo Y; Roderick P; Tomson CR
    Nephron Clin Pract; 2011; 119(1):c10-7; discussion c17. PubMed ID: 21659780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of the nephrologist in the intensive care unit.
    Charytan C; Kaplan AA; Paganini EP; Weiss J; Owen WF
    Am J Kidney Dis; 2001 Aug; 38(2):426-9. PubMed ID: 11479174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Integration of a psychologist into Nephrology-Dialysis-Hypertension Operative Unit: from needs evaluation to the definition of an intervention model].
    Monica RM; Delli Zotti GB; Spotti D; Sarno L
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The nephrologist as a primary care provider for the hemodialysis patient.
    Shah N; Dahl NV; Kapoian T; Sherman RA; Walker JA
    Int Urol Nephrol; 2005; 37(1):113-7. PubMed ID: 16132772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of the results of chronic hemodialysis therapy in Gda'nsk during the 15-year period 1969-1983. I. Patients' qualifications, arteriovenous fistula, general data and methods of hemodialysis therapy].
    Rutkowski B; Niemierko J; Labon M; Spineter-Sokołowska E; Wielgosz A; Manitius A
    Pol Arch Med Wewn; 1987 Jul; 78(1):8-16. PubMed ID: 3271287
    [No Abstract]   [Full Text] [Related]  

  • 60. Message to the FDA on ESAs: REMS is not enough, more studies are needed.
    Singh AK
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1355-8. PubMed ID: 20688885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.